Search Results - "KALRA, Dipak"

The importance of real-world data to precision medicine by Kalra, Dipak

Get more information

Editorial: Managing healthcare transformation towards P5 medicine by Blobel, Bernd, Kalra, Dipak

Get full text

Using electronic health records for clinical research: The case of the EHR4CR project by De Moor, Georges, Sundgren, Mats, Kalra, Dipak, Schmidt, Andreas, Dugas, Martin, Claerhout, Brecht, Karakoyun, Töresin, Ohmann, Christian, Lastic, Pierre-Yves, Ammour, Nadir, Kush, Rebecca, Dupont, Danielle, Cuggia, Marc, Daniel, Christel, Thienpont, Geert, Coorevits, Pascal

“…[Display omitted] •EHR4CR has designed a secure platform to optimise clinical trial protocols.•The EHRCR platform facilitates patient identification and…”
Get full text

Can OpenEHR, ISO 13606, and HL7 FHIR Work Together? An Agnostic Approach for the Selection and Application of Electronic Health Record Standards to the Next-Generation Health Data Spaces by Pedrera-Jiménez, Miguel, García-Barrio, Noelia, Frid, Santiago, Moner, David, Boscá-Tomás, Diego, Lozano-Rubí, Raimundo, Kalra, Dipak, Beale, Thomas, Muñoz-Carrero, Adolfo, Serrano-Balazote, Pablo

“…In order to maximize the value of electronic health records (EHRs) for both health care and secondary use, it is necessary for the data to be interoperable and…”
Get full text

Editorial: Personal Health Systems by Kalra, Dipak, Strübin, Michael

Get full text

Frameworks, Dimensions, Definitions of Aspects, and Assessment Methods for the Appraisal of Quality of Health Data for Secondary Use: Comprehensive Overview of Reviews by Declerck, Jens, Kalra, Dipak, Vander Stichele, Robert, Coorevits, Pascal

“…Health care has not reached the full potential of the secondary use of health data because of-among other issues-concerns about the quality of the data being…”
Get full text

Success Factors for Scaling Up the Adoption of Digital Therapeutics Towards the Realization of P5 Medicine by Prodan, Alexandra, Deimel, Lucas, Ahlqvist, Johannes, Birov, Strahil, Thiel, Rainer, Toivanen, Meeri, Kolitsi, Zoi, Kalra, Dipak

“…Digital therapeutics (DTx) can be a valuable contribution to the successful scale up of P5 Medicine (personalized, participatory, predictive, preventive,…”
Get full text

Approaches to recording drug allergies in electronic health records: qualitative study by Fernando, Bernard, Morrison, Zoe, Kalra, Dipak, Cresswell, Kathrin, Sheikh, Aziz

“…Drug allergy represent an important subset of adverse drug reactions that is worthy of attention because many of these reactions are potentially preventable…”
Get full text

How Do Clinical Information Systems Affect the Cognitive Demands of General Practitioners?: Usability Study with a Focus on Cognitive Workload by Ariza, Ferran, Kalra, Dipak, Potts, Henry Ww

“…Clinical information systems in the National Health Service do not need to conform to any explicit usability requirements. Poor usability can increase the…”
Get full text

How Can a Clinical Data Modelling Tool Be Used to Represent Data Items of Relevance to Paediatric Clinical Trials? Learning from the Conect4children (c4c) Consortium by Amadi, Chima, Leary, Rebecca, Palmeri, Avril, Hedley, Victoria, Sen, Anando, Siddiqui, Rahil Qamar, Kalra, Dipak, Straub, Volker

“…Data dictionaries for clinical trials are often created manually, with data structures and controlled vocabularies specific for a trial or family of trials…”
Get full text

Artificial intelligence based data curation: enabling a patient-centric European health data space by de Zegher, Isabelle, Norak, Kerli, Steiger, Dominik, Müller, Heimo, Kalra, Dipak, Scheenstra, Bart, Cina, Isabella, Shulz, Stefan, Uma, Kanimozhi, Kalendralis, Petros, Lotmam, Eno-Martin, Benedikt, Martin, Dumontier, Michel, Celebi, Remzi

“…The emerging European Health Data Space (EHDS) Regulation opens new prospects for large-scale sharing and re-use of health data. Yet, the proposed regulation…”
Get full text

"There are too many, but never enough": qualitative case study investigating routine coding of clinical information in depression by Cresswell, Kathrin, Morrison, Zoe, Kalra, Dipak, Sheikh, Aziz

“…We sought to understand how clinical information relating to the management of depression is routinely coded in different clinical settings and the…”
Get full text

Standing the test of COVID-19: charting the new frontiers of medicine by Simon Cauchemez, Giulio Cossu, Giulio Cossu, Giulio Cossu, Nathalie Delzenne, Eran Elinav, Eran Elinav, Didier Fassin, Alain Fischer, Alain Fischer, Alain Fischer, Alain Fischer, Thomas Hartung, Thomas Hartung, Dipak Kalra, Mihai Netea, Mihai Netea, Johan Neyts, Johan Neyts, Johan Neyts, Rino Rappuoli, Rino Rappuoli, Rino Rappuoli, Mariagrazia Pizza, Melanie Saville, Pamela Tenaerts, Gerry Wright, Philippe Sansonetti, Philippe Sansonetti, Michel Goldman

“…The COVID-19 pandemic accelerated research and innovation across numerous fields of medicine. It emphasized how disease concepts must reflect dynamic and…”
Get full text

Quality of Hospital Electronic Health Record (EHR) Data Based on the International Consortium for Health Outcomes Measurement (ICHOM) in Heart Failure: Pilot Data Quality Assessment Study by Aerts, Hannelore, Kalra, Dipak, Sáez, Carlos, Ramírez-Anguita, Juan Manuel, Mayer, Miguel-Angel, Garcia-Gomez, Juan M, Durà-Hernández, Marta, Thienpont, Geert, Coorevits, Pascal

“…There is increasing recognition that health care providers need to focus attention, and be judged against, the impact they have on the health outcomes…”
Get full text

Identification of Drugs Acting as Perpetrators in Common Drug Interactions in a Cohort of Geriatric Patients from Southern Italy and Analysis of the Gene Polymorphisms That Affect Their Interacting Potential by Cataldi, Mauro, Celentano, Camilla, Bencivenga, Leonardo, Arcopinto, Michele, Resnati, Chiara, Manes, Annalaura, Dodani, Loreta, Comnes, Lucia, Vander Stichele, Robert, Kalra, Dipak, Rengo, Giuseppe, Giallauria, Francesco, Trama, Ugo, Ferrara, Nicola, Cittadini, Antonio, Taglialatela, Maurizio

“…Pharmacogenomic factors affect the susceptibility to drug-drug interactions (DDI). We identified drug interaction perpetrators among the drugs prescribed to a…”
Get full text

Comparison and transformation between CDISC ODM and EN13606 EHR standards in connecting EHR data with clinical trial research data by Tapuria, Archana, Bruland, Philipp, Delaney, Brendan, Kalra, Dipak, Curcin, Vasa

“…Objectives Integrating Electronic Health Record (EHR) systems into the field of clinical trials still contains several challenges and obstacles. Heterogeneous…”
Get full text

Contribution of Clinical Archetypes, and the Challenges, towards Achieving Semantic Interoperability for EHRs by Tapuria, Archana, Kalra, Dipak, Kobayashi, Shinji

“…The objective is to introduce 'clinical archetype' which is a formal and agreed way of representing clinical information to ensure interoperability across and…”
Get full text

Development of the CDISC Pediatrics User Guide: a CDISC and conect4children collaboration by Owen, John, Sen, Anando, Aurich, Beate, Engel, Corinna, Cavallaro, Giacomo, Degraeuwe, Eva, Kalra, Dipak, Cornet, Ronald, Walsh, Melissa, Berkery, Teresa, Palmeri, Avril, Mahler, Fenna, Malik, Salma, Persijn, Laura, Amadi, Chima, Thuet, Jacques, Woodworth, Simon, Nally, Sinead, Leary, Rebecca, Marshall, Richard, Straub, Volker

“…The conect4children (c4c) project aims to facilitate efficient planning and delivery of paediatric clinical trials. One objective of c4c is data…”
Get full text

Correction: “There Are Too Many, but Never Enough": Qualitative Case Study Investigating Routine Coding of Clinical Information in Depression by Cresswell, Kathrin, Morrison, Zoe, Kalra, Dipak, Sheikh, Aziz

“…Kathrin Cresswell1*, Zoe Morrison1, Dipak Kalra2, Aziz Sheikh11 eHealth Research Group, Centre for Population Health Sciences, The University of Edinburgh,…”
Get full text

Making Sure That Orphan Incentives Tip the Right Way in Europe by Horgan, Denis, Koeva-Balabanova, Jasmina, Capoluongo, Ettore, Jagielska, Beata, Cattaneo, Ivana, Kozaric, Marta, Tumiene, Birute, El Ahl, Jean-Paul, Lal, Jonathan A, Kalra, Dipak, Malats, Núria

“…The delicate balance of funding research and development of treatments for rare disease is only imperfectly achieved in Europe, and even the current…”
Get full text